These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Targeting protein kinases in cancer therapy.
    Author: Fabbro D, García-Echeverría C.
    Journal: Curr Opin Drug Discov Devel; 2002 Sep; 5(5):701-12. PubMed ID: 12630290.
    Abstract:
    Over the years, many different tyrosine and serine/threonine protein kinases have been selected as candidates for drug discovery activities in oncology research, based either on their overexpression and/or dysfunction in a particular organ or tissue, or through their association in deregulated signal transduction/cell cycle pathways. This review summarises current preclinical and clinical knowledge of ATP-competitive, small molecule kinase inhibitors, and receptor or ligand-competitive antibodies of selected protein kinases in which drug discovery and development activities have advanced with some success.
    [Abstract] [Full Text] [Related] [New Search]